Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES study

1. Reinhart, K.
2. Menges, T.
3. Gardlund, B.
4. Zwaveling, J.
5. Smithes, M.
6. Vincent, J.-L.
7. Tellado, J.M.
8. Salgado-Remigio, A.
9. Zimlichman, R.
10. Withington, S.
11. Tschaikowsky, K.
12. Brase, R.
13. Damas, P.
14. Kupper, H.
15. Kempeni, J.
16. Eiselstein, J.
17. Kaul, M.